Solvent abuse-related toluene leukoencephalopathy

Journal of Clinical Forensic Medicine

Volumn 10, Issue 2, 2003, Pages 93-95

  Fornazzari, Luis ^a   Pollanen, Michael S ^b   Myers, Vicki ^a,c   Wolf, Amparo ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b Provincial Forensic Pathology Unit   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Dementia; Leukoencephalopathy; Solvent; Toluene; White matter

Indexed keywords

SOLVENT; TOLUENE;

ADULT; ARTICLE; BRAIN DYSFUNCTION; BRAIN INJURY; CASE REPORT; CEREBELLUM; CLINICAL FEATURE; DEATH; DEMENTIA; HUMAN; HUMAN CELL; LEUKOENCEPHALOPATHY; MACROPHAGE; MALE; NERVE DEGENERATION; NERVE FIBER; NEUROPATHOLOGY; PREFRONTAL CORTEX; SUBSTANCE ABUSE; VAPOR; WHITE MATTER;

EID: 0038819986     PISSN: 13531131     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-1131(03)00035-X     Document Type: Article

References (10)

1. Oetting ER, Webb J. Psychosocial characteristics and their links with inhalants, a research agenda. In: Sharp CW, Beauvais F, Spence R (eds.) Inhalant Abuse: A Volatile Research Agenda. NIDA Research Monograph Series, 129. Washington, DC: National Institutes of Health, 1992; 59-98. NIH publication 93-3480.
2. Sharp CW, Rosenberg NL. Inhalants. In: Lowinson JH, Ruiz P, Millman RB, Langrod JG (eds.) Substance Abuse: A Comprehensive Textbook. Baltimore, MD: Williams and Wilkins, 1998; 246-264
3. Rosenberg NL, Kleinschmidt-DeMasters BK, Dreisbach JN, Hormes JT, Filley CM. Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol 1988; 23: 611-614.
4. Hormes JT, Filley CM, Rosenberg NL. Neurological sequelae of chronic solvent vapor abuse. Neurology 1986; 36: 698-702.
5. Fornazzari L, Wilkinson DA, Kapur BM, Carlen PL. Cerebellar, cortical and functional impairment in toluene abusers. Acta Neurol Scand 1983; 67: 319-329.
6. Jacobs AM, Ghodse AH. Delinquency and regular solvent abuse: an unfavourable combination. British Journal of Addiction 1988; 83: 965-968.
7. Filley CM, Franklin GM, Heaton RK, Rosenberg NL. White matter dementia: clinical disorders and implications. Neuropsychiatry Neuropsychol Behav Neurol 1988; 1: 239-254.
8. Yamanouchi N, Okada S, Kodama K, Sakamoto T et al. Effects of MRI abnormalities on WAIS-R performance in solvent abusers. Acta Neurol Scand 1997; 96: 34-39.
9. Filley CM, Heaton RK, Rosenberg NL. White matter dementia in chronic toluene abuse. Neurology 1990;40: 532-534.
10. Yamanouchi N, Okada S, Kodama S et al. White matter changes caused by chronic solvent abuse. Am J Neuroradiol 1995; 16: 1643-1649.